# Intranasal Oxytocin for Methamphetamine Withdrawal in Women

> **NCT05760807** · NA · COMPLETED · sponsor: **Turning Point** · enrollment: 10 (actual)

## Conditions studied

- Methamphetamine Use Disorder

## Interventions

- **DRUG:** Oxytocin nasal spray

## Key facts

- **NCT ID:** NCT05760807
- **Lead sponsor:** Turning Point
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-29
- **Primary completion:** 2024-03-28
- **Final completion:** 2024-03-28
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-04-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05760807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05760807, "Intranasal Oxytocin for Methamphetamine Withdrawal in Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05760807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*